Patrick Van Berkel

Biography

  van Berkel is Senior Vice President Research & Development at ADC Therapeutics and has more than twenty years’ experience in the biotech industry, specializing in the development of antibody-based therapeutics. Prior to joining ADC Therapeutics, Dr. van Berkel spent more than nine years with Genmab as Vice President of Antibody Technology and most recently as Vice President of CMC R&D. Dr. van Berkel has a chemistry degree from the University of Nijmegen, The Netherlands (1991) and did his thesis at the University of Leiden, The Netherlands (1998).

Research Interest